A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2
暂无分享,去创建一个
[1] J. Kinet,et al. Activation of BTK by a Phosphorylation Mechanism Initiated by SRC Family Kinases , 1996, Science.
[2] K. Sada,et al. Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling , 1995, The Journal of experimental medicine.
[3] M. Vihinen. BTKbase: a database of XLA-causing mutations , 1995 .
[4] J. Fargnoli,et al. Src family protein tyrosine kinases induce autoactivation of Bruton's tyrosine kinase , 1995, Molecular and cellular biology.
[5] T. Kurosaki,et al. Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis , 1995, The Journal of experimental medicine.
[6] R. Perlmutter,et al. Impaired expansion of mouse B cell progenitors lacking Btk. , 1995, Immunity.
[7] F. Alt,et al. Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.
[8] R. Rowley,et al. Syk protein-tyrosine kinase is regulated by tyrosine-phosphorylated Ig alpha/Ig beta immunoreceptor tyrosine activation motif binding and autophosphorylation , 1995, The Journal of Biological Chemistry.
[9] A. Satterthwaite,et al. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. , 1995, Immunity.
[10] M. Nussenzweig,et al. The role of Ig beta in precursor B cell transition and allelic exclusion. , 1995, Science.
[11] R. Lovering,et al. The protein defective in X‐linked agammaglobulinemia, Bruton's tyrosine kinase, shows increased autophosphorylation activity in vitro when isolated from cells in which the B cell receptor has been cross‐linked , 1995, European journal of immunology.
[12] T. Kurosaki,et al. Tyrosine Phosphorylation of Shc Is Mediated through Lyn and Syk in B Cell Receptor Signaling (*) , 1995, The Journal of Biological Chemistry.
[13] A. DeFranco,et al. Transmembrane signaling by antigen receptors of B and T lymphocytes. , 1995, Current opinion in cell biology.
[14] J. Bolen. Protein tyrosine kinases in the initiation of antigen receptor signaling. , 1995, Current opinion in immunology.
[15] C. Larsson,et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. , 1994, Oncogene.
[16] K. Isselbacher,et al. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Hendriks,et al. B-cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked agammaglobulinemia. , 1994, The Journal of biological chemistry.
[18] J. Fargnoli,et al. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Hajduk,et al. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate , 1994, Nature.
[20] J. Cambier,et al. The B-cell antigen receptor complex: structure and signal transduction. , 1994, Immunology today.
[21] Andrew H. Liu,et al. THE GENE INVOLVED IN X-LINKED AGAMMAGLOBULINEMIA IS A MEMBER OF THE SRC FAMILY OF PROTEIN-TYROSINE KINASES , 1994, Pediatrics.
[22] Y. Ohta,et al. TXK, a novel human tyrosine kinase expressed in T cells shares sequence identity with Tec family kinases and maps to 4p12. , 1994, Human molecular genetics.
[23] T. Yamamoto,et al. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling , 1994, The Journal of experimental medicine.
[24] I. Vořechovský,et al. X‐Linked Agammaglobulinemia and Other Immunoglobulin Deficiencies , 1994, Immunological reviews.
[25] O. Witte,et al. Bruton's Tyrosine Kinase is a Key Regulator in B‐Cell Development , 1994, Immunological reviews.
[26] A. Hata,et al. Tyrosine kinases Lyn and Syk regulate B cell receptor‐coupled Ca2+ mobilization through distinct pathways. , 1994, The EMBO journal.
[27] Dan R. Littman,et al. Signal transduction by lymphocyte antigen receptors , 1994, Cell.
[28] J. Cambier,et al. Signal transduction by the B cell antigen receptor and its coreceptors. , 1994, Annual review of immunology.
[29] R. Hendriks,et al. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. , 1994, Human molecular genetics.
[30] R. Lovering,et al. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. , 1994, Human molecular genetics.
[31] D J Rawlings,et al. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. , 1993, Science.
[32] W. Paul,et al. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. , 1993, Science.
[33] D. Mason,et al. Antigen Receptors on T and B Lymphocytes: Parallels in Organization and Function , 1993, Immunological reviews.
[34] N. Copeland,et al. Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit. , 1993, Oncogene.
[35] S. Desiderio,et al. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[36] T. Pawson,et al. SH2 and SH3 domains: From structure to function , 1992, Cell.
[37] H. Michel,et al. Identification of Tyr-185 as the site of tyrosine autophosphorylation of recombinant mitogen-activated protein kinase p42mapk. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Reth. Antigen receptors on B lymphocytes. , 1992, Annual review of immunology.
[39] F. Hanaoka,et al. Blasticidin S-resistance gene (bsr): a novel selectable marker for mammalian cells. , 1991, Experimental cell research.
[40] H. Nakamura,et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. , 1991, The Journal of biological chemistry.
[41] A. Burkhardt,et al. Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinases. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[42] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[43] T. Yamamoto,et al. Association of B cell antigen receptor with protein tyrosine kinase Lyn. , 1991, Science.
[44] H. Mano,et al. A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. , 1990, Oncogene.
[45] M. Harnett,et al. Analysis of signaling via surface immunoglobulin receptors on b cells from cba/n mice , 1989, European journal of immunology.
[46] K. Kammermeyer,et al. Primary sequence and developmental expression of a novel Drosophila melanogaster src gene , 1987, Molecular and cellular biology.
[47] R. Tsien,et al. A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.
[48] F. Finkelman,et al. Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig. , 1983, Journal of immunology.
[49] M. Berridge,et al. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. , 1983, The Biochemical journal.
[50] F. Melchers,et al. Frequencies of mitogen‐reactive B cells in the mouse. Lipopolysaccharide‐, lipoprotein‐ and Nocardia mitogen‐reactive B cells in CBA/N mice , 1979, European journal of immunology.
[51] W. Paul,et al. X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect , 1975, The Journal of experimental medicine.
[52] P. Baker,et al. Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. , 1972, The Journal of experimental medicine.